Anavex Life Sciences Corp (AVXL)

[nobrainerstocks]

Anavex is developing its Alzheimer's treatment based on guidance from the FDA so I doubt they violate protocols unless the FDA allows it.

To quote Xena in an older post:

Anavex is interacting with the FDA - they've stated this. The FDA sets up the guide lines and decides in the end what is acceptable and what is not. The FDA can dictate changes to the trial even after it has started.

Yes, the company studies the data from the P2 and based on what they've learned they suggest a protocol, but it must be approved by the FDA.